{"count": 8, "results": [{"_id": "11061055", "pmid": 11061055, "title": "Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.", "journal": "Clin Cardiol", "authors": ["Pehrsson SK", "Ringqvist I", "Ekdahl S", "Karlson BW", "Ulvenstam G", "Persson S"], "date": "2000-10-01T00:00:00Z", "doi": "10.1002/clc.4960231014", "meta_date_publication": "2000 Oct", "meta_volume": "23", "meta_issue": "10", "meta_pages": "763-70", "score": 50064.375, "text_hl": "METHODS: @SPECIES_9606 @@@Patients@@@ with @DISEASE_Angina_Stable @DISEASE_MESH:D060050 @@@stable angina pectoris@@@ and @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST@@@ @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@ during exercise and ambulatory monitoring were randomized to receive @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (n = 116) or @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ (n = 116), or both (n = 119). ", "citations": {"NLM": "Pehrsson SK, Ringqvist I, Ekdahl S, Karlson BW, Ulvenstam G, Persson S. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris. Clin Cardiol. 2000 Oct;23(10):763-70. PMID: 11061055", "BibTeX": "@article{11061055, title={Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.}, author={Pehrsson SK and Ringqvist I and Ekdahl S and Karlson BW and Ulvenstam G and Persson S}, journal={Clin Cardiol}, volume={23}, number={10}, pages={763-70}}"}}, {"_id": "9380807", "pmid": 9380807, "title": "[Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].", "journal": "Przegl Lek", "authors": ["Witkowska M", "Tracz W", "Kubler G", "Negrusz-Kawecka M", "Hlawaty M", "Olszowska M", "Salamon P"], "date": "1997-01-01T00:00:00Z", "meta_date_publication": "1997", "meta_volume": "54", "meta_issue": "5", "meta_pages": "324-8", "score": 50060.02, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ treatment resulted in significant increase in total exercise time, increase the exercise time to @DISEASE_Angina_Pectoris @DISEASE_MESH:D000787 @@@angina@@@ onset, increase time to @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST segment@@@ @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@, decrease in @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST segment@@@ @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@, decrease in total duration of @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST segment@@@ @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@ and decrease in duration of @DISEASE_Pain @DISEASE_MESH:D010146 @@@pain@@@. ", "citations": {"NLM": "Witkowska M, Tracz W, Kubler G, Negrusz-Kawecka M, Hlawaty M, Olszowska M, Salamon P. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension]. Przegl Lek. 1997;54(5):324-8. PMID: 9380807", "BibTeX": "@article{9380807, title={[Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].}, author={Witkowska M and Tracz W and Kubler G and Negrusz-Kawecka M and Hlawaty M and Olszowska M and Salamon P}, journal={Przegl Lek}, volume={54}, number={5}, pages={324-8}}"}}, {"_id": "7860905", "pmid": 7860905, "title": "Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.", "journal": "J Am Coll Cardiol", "authors": ["Davies RF", "Habibi H", "Klinke WP", "Dessain P", "Nadeau C", "Phaneuf DC", "Lepage S", "Raman S", "Herbert M", "Foris K"], "date": "1995-03-01T00:00:00Z", "doi": "10.1016/0735-1097(94)00436-t", "meta_date_publication": "1995 Mar 1", "meta_volume": "25", "meta_issue": "3", "meta_pages": "619-25", "score": 50057.234, "text_hl": "Each group underwent a counterbalanced, crossover evaluation of single drug and placebo, followed by evaluation of the combination. RESULTS: @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ and the combination prolonged exercise time to 0.1-mV @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST segment depression@@@ by 29% and 34%, respectively (p < 0.001) versus 3% for @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ (p = NS). ", "citations": {"NLM": "Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, Lepage S, Raman S, Herbert M, Foris K. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators. J Am Coll Cardiol. 1995 Mar 1;25(3):619-25. PMID: 7860905", "BibTeX": "@article{7860905, title={Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS) Investigators.}, author={Davies RF and Habibi H and Klinke WP and Dessain P and Nadeau C and Phaneuf DC and Lepage S and Raman S and Herbert M and Foris K}, journal={J Am Coll Cardiol}, volume={25}, number={3}, pages={619-25}}"}}, {"_id": "7522284", "pmid": 7522284, "title": "Long-term efficacy of amlodipine in patients with severe coronary artery disease.", "journal": "J Cardiovasc Pharmacol", "authors": ["Navarro Estrada JL", "Oliveri R"], "date": "1993-01-01T00:00:00Z", "meta_date_publication": "1993", "meta_volume": "22 Suppl A", "meta_issue": "", "meta_pages": "S24-8", "score": 50056.715, "text_hl": "@<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-segment depression@@@ at maximum common load was reduced when compared with baseline values (p < 0.001), and the metabolic equivalent (MET) score at peak exercise was significantly improved by @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (p < 0.001). ", "citations": {"NLM": "Navarro Estrada JL, Oliveri R. Long-term efficacy of amlodipine in patients with severe coronary artery disease. J Cardiovasc Pharmacol. 1993;22 Suppl A():S24-8. PMID: 7522284", "BibTeX": "@article{7522284, title={Long-term efficacy of amlodipine in patients with severe coronary artery disease.}, author={Navarro Estrada JL and Oliveri R}, journal={J Cardiovasc Pharmacol}, volume={22 Suppl A}, pages={S24-8}}"}}, {"_id": "23288106", "pmid": 23288106, "title": "The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.", "journal": "J Cardiovasc Pharmacol", "authors": ["Fujisawa M", "Yorikane R", "Matsuoka Y", "Koike H", "Ueno K"], "date": "2013-01-01T00:00:00Z", "doi": "10.1097/FJC.0b013e3182776c28.", "meta_date_publication": "2013 Jan", "meta_volume": "61", "meta_issue": "1", "meta_pages": "63-9", "score": 50056.62, "text_hl": "Oral administration of @CHEMICAL_azelnidipine @CHEMICAL_MESH:C061679 @@@azelnidipine@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ produced long lasting inhibition of arginine vasopressin-induced @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-segment depression@@@ in electrocardiogram. ", "citations": {"NLM": "Fujisawa M, Yorikane R, Matsuoka Y, Koike H, Ueno K. The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine. J Cardiovasc Pharmacol. 2013 Jan;61(1):63-9. PMID: 23288106", "BibTeX": "@article{23288106, title={The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine.}, author={Fujisawa M and Yorikane R and Matsuoka Y and Koike H and Ueno K}, journal={J Cardiovasc Pharmacol}, volume={61}, number={1}, pages={63-9}}"}}, {"_id": "23107869", "pmid": 23107869, "title": "The pharmacological differences in anti-anginal effects of long-lasting calcium channel blockers:  azelnidipine and amlodipine.", "journal": "J Cardiovasc Pharmacol", "authors": ["Michio F", "Ryosuke Y", "Yuko M", "Hiroyuki K", "Koichi U"], "date": "2012-10-26T00:00:00Z", "doi": "10.1097/FJC.0b013e3182776c28", "meta_date_publication": "2012 Oct 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50055.758, "text_hl": "Oral administration of @CHEMICAL_azelnidipine @CHEMICAL_MESH:C061679 @@@azelnidipine@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ produced long-lasting inhibition of AVP-induced @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-segment depression@@@ in ECG. ", "citations": {"NLM": "Michio F, Ryosuke Y, Yuko M, Hiroyuki K, Koichi U. The pharmacological differences in anti-anginal effects of long-lasting calcium channel blockers:  azelnidipine and amlodipine. J Cardiovasc Pharmacol. 2012 Oct 26;():. PMID: 23107869", "BibTeX": "@article{23107869, title={The pharmacological differences in anti-anginal effects of long-lasting calcium channel blockers:  azelnidipine and amlodipine.}, author={Michio F and Ryosuke Y and Yuko M and Hiroyuki K and Koichi U}, journal={J Cardiovasc Pharmacol}}"}}, {"_id": "26594114", "pmid": 26594114, "pmcid": "PMC4605908", "title": "The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats", "journal": "Saudi Pharm J", "authors": ["Al-Zahrani YA", "Al-Harthi SE", "Khan LM", "El-Bassossy HM", "Edris SM", "A Sattar MA"], "date": "2015-10-01T00:00:00Z", "doi": "10.1016/j.jsps.2014.12.001", "meta_date_publication": "2015 Oct", "meta_volume": "23", "meta_issue": "5", "meta_pages": "487-98", "score": 50050.16, "text_hl": "Furthermore, all @CHEMICAL_Allopurinol @CHEMICAL_MESH:D000493 @@@allopurinol@@@ doses (31, 62 and 93 mg/kg/day) exhibited a significant decrease in the onset to @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-segment depression@@@ and a significant increase in the duration of @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST-segment depression@@@ respectively compared to @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ group (Tables 1 and 2). ", "citations": {"NLM": "Al-Zahrani YA, Al-Harthi SE, Khan LM, El-Bassossy HM, Edris SM, A Sattar MA. The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats Saudi Pharm J. 2015 Oct;23(5):487-98. PMID: 26594114", "BibTeX": "@article{26594114, title={The possible antianginal effect of allopurinol in vasopressin-induced ischemic model in rats}, author={Al-Zahrani YA and Al-Harthi SE and Khan LM and El-Bassossy HM and Edris SM and A Sattar MA}, journal={Saudi Pharm J}, volume={23}, number={5}, pages={487-98}}"}}, {"_id": "16936473", "pmid": 16936473, "title": "Heart rate slowing versus other pharmacological antianginal strategies.", "journal": "Adv Cardiol", "authors": ["Diaz A", "Tardif JC"], "date": "2006-01-01T00:00:00Z", "doi": "10.1159/000095429", "meta_date_publication": "2006", "meta_volume": "43", "meta_issue": "", "meta_pages": "65-78", "score": 50031.43, "text_hl": "In another trial of 1,195 @SPECIES_9606 @@@patients@@@, time to 1mm @<m>DISEASE_ST_Elevation_Myocardial_Infarction</m> @DISEASE_MESH:D000072657 @@@ST segment@@@ @DISEASE_Depressive_Disorder @DISEASE_MESH:D003866 @@@depression@@@ was increased by 45 s with @CHEMICAL_Ivabradine @CHEMICAL_MESH:D000077550 @@@ivabradine@@@ 7.5 mg b.i.d. and by 40 s with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 10 mg daily. ", "citations": {"NLM": "Diaz A, Tardif JC. Heart rate slowing versus other pharmacological antianginal strategies. Adv Cardiol. 2006;43():65-78. PMID: 16936473", "BibTeX": "@article{16936473, title={Heart rate slowing versus other pharmacological antianginal strategies.}, author={Diaz A and Tardif JC}, journal={Adv Cardiol}, volume={43}, pages={65-78}}"}}]}